Home Authors Posts by Sarah Pringle

Sarah Pringle

Housatonic Partners, Aegis Treatment Centers, opioid, addiction, healthcare, private equity, merger, M&A
Revelstoke investment dates to January 2015 Financial advisers: Harris Williams, Cain Brothers Other opioid-treatment players in the market: Housatonic’s Aegis Revelstoke Capital Partners has kicked off its sales process for Crossroads Treatment Centers, according to two sources familiar with the matter. The Denver PE firm expects to field first round bids later this month for […]
healthcare, private equity, medicine
Trending this week: healthcare payer services
New Mountain Capital, Convey Health, healthcare, private equity, merger, m&a
Company projects ~$50 mln 2019 Ebitda First-round bids next week Florida company merged with HealthScape, Pareto in November New Mountain Capital is evaluating the sale of healthcare payer services company Convey Health Solutions, according to five people familiar with the matter. The New York PE firm has engaged Barclays Capital and Goldman Sachs for sell-side […]
WindRose Health, fertility, in vitro, healthcare, private equity, merger, m&a, Ovation Fertility
WindRose formed Ovation in ’15 through fusion of 4 labs Harris Williams advises Los Angeles fertility treatment company Other investors in fertility space: Lee Equity, TA, Warburg WindRose Health Investors is evaluating the sale of Ovation Fertility, a network of in vitro fertility and genetic testing labs, four sources said. Second round bids for the […]
BC Partners, Antelliq, agritech, healthcare, merger, M&A, private equity, Merck, pharma, animal health, veterinary
BC Partners achieves ~30 pct IRR, $1.3 bln capital gain European buyout shop’s investment dates to 2013 French agritech company joins Merck’s animal health unit BC Partners generated a more than 3x return on Antelliq Corp, the French maker of digital monitoring products for the animal health industry, according to a source familiar with the […]
CD&R, Tranzact, private equity, fintech, merger, M&A
Including earnout, gross MOI could increase to as much as 3.4x Company’s Ebitda grew at 13 pct CAGR during CD&R’s
Charme Capital Partners, EQT Partners, Igenomix, genetics, healthcare, Spain, private equity, merger, m&a
Genetic-testing services in 13 countries; U.S. largest market Partial exit is first for Charme III Igenomix tests grew at ~44 pct CAGR during Charme’s hold Charme Capital Partners is poised to make more than 4x its money through its majority stake sale of Igenomix, according to a source familiar with the matter. The buyer is […]
healthcare, private equity, medicine
Boston investors “bring it home” via health tech
Mason Wells, Nelipak, healthcare, pharma, medical devices, packaging, private equity, merger, m&a
Mason Wells formed Nelipak via Sealed Air carveout in ’13 1st round bids due this week Produce expected to produce low double-digit multiple Mason Wells is evaluating the sale of Nelipak Healthcare Packaging, a global provider of everything from thermoformed medical trays to pharmaceutical packaging, according to two people familiar with the situation. The Midwestern-focused […]
Sean Cunningham, GTCR, healthcare, merger, m&a, NuVasive, Gregory Lucier
Lucier led Life Technologies through sale to Thermo Fisher Ex-GreatCall CFO Berning takes post at Corza New company will look at carveouts, investments in founder-owned business In its latest executive-driven effort, GTCR joined forces with industry veteran Gregory Lucier to hunt for deals across life sciences and medical technology. Lucier will be CEO of newly created Corza […]
pehub
pehub

Copyright PEI Media

Not for publication, email or dissemination